This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Events & Webinars

Expert Perspectives in Colorectal Cancer Care - video series 2

ESMO-GI

Stivarga-BG

Join our Expert Faculty to learn about clinical areas of interest in the management of colorectal cancer, to hear their practical experience-based insights on a range of topics.

These include reviewing the benefits of oral vs IV treatment in the metastatic colorectal cancer setting, the advantages to considering different treatment mechanisms of action to manage mCRC, the importance of anti-angiogenic strategies in managing CRC and experiences of using Stivarga® (regorafenib) in advanced disease, including discussion of patient profiles likely to best benefit from this treatment.

 

Expert faculty includes Dr Sheela Rao, London, Dr Harpreet Wasan, London and Dr Elena Elez, Barcelona.

 

This video series is organised and funded by Bayer plc.

Video 1
Video 2
Video 3
Speakers
    • sheela_rao
      Dr Sheela Rao

    Dr Rao is a Consultant Medical Oncologist specialising in gastrointestinal cancers and cancers of unknown primary within the Gastrointestinal Unit at the Royal Marsden Hospital. Dr Rao completed medical training at Charing Cross and Westminster Medical School and specialist oncology training at The Royal Marsden. She undertook laboratory-based research at The Institute of Cancer Research, supported by an academic grant, examining the prognostic and predictive value of genomic profiling of tumour biopsies in oesophago-gastric cancer. She is The Royal Marsden's lead for cancers of unknown primary. Her research interests include clinical trials with novel therapies in GI cancers and she is the Principal investigator on a number of national and international trials with novel agents and immunotherapy. She serves on the committees for the UK National Cancer Research Institute (NCRI) Colorectal Cancer and Anal-Rectal Clinical Study Groups and is an active member of the International Rare Cancers Initiative (IRCI). She serves on the European Society of Medical Oncology (ESMO) educational faculty for GI Tumours. She sits on a number of national and international trial management groups and data monitoring committees.

    • harpreet_wasan
      Dr Harpreet Wasan

    Harpreet Wasan is a Professor in Medical Oncology and leads the gastrointestinal clinical research program at Hammersmith Hospital, Imperial College London and is current Lead for Cancer for The N.W. London NIHR Research network. His research interests cover CRC, Biliary, Pancreatic Cancer & CUP and has led and participated in trials that have led to global new standards of care with interests in designing and implementing novel paradigm & interventional trials (including non-drug interventions) in GI cancer.

Expert Perspectives in CRC - video series 1 (UKOF)
Stivarga® (regorafenib)
PP-STI-GB-0398, July 2024
Empowering Nurses for Colorectal Cancer Care
Stivarga® (regorafenib)
PP-STI-GB-0396, July 2024
Frontiers at St Mark’s 2023
Stivarga® (regorafenib)
PP-STI-GB-0397, July 2024

PP-STI-GB-0399 | July 2024